Also trades as: DOSE.CN (CNQ) · $vol 0M
RDTCF OTC
Rapid Dose Therapeutics Corp.
1W: -16.9%
1M: -16.9%
3M: +434.9%
YTD: -21.6%
1Y: -49.1%
3Y: +253.0%
5Y: -71.8%
$0.07
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$270K
+76.4% ▲
Capital Expenditures
$895
+84.4% ▲
5Y CAGR: -37.1%
Free Cash Flow
-$271K
+76.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8K
+94.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$4M | -$4M | -$5M | -$3M |
| Depreciation & Amort. | $766K | $627K | $620K | $241K | $513K |
| Stock-Based Comp. | $2M | $707K | $162K | $1M | $0 |
| Change in Working Capital | -$1M | $1M | -$119K | $2M | $1M |
| Other Non-Cash Items | $4M | $121K | $1M | $1M | $1M |
| Operating Cash Flow | -$3M | -$864K | -$2M | -$1M | -$270K |
| — Investing Activities — | |||||
| Capital Expenditures | -$40K | $0 | $0 | -$6K | -$898 |
| Acquisitions (Net) | $2M | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $2M | $0 | $0 | -$6K | -$898 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$286K | $452K | $1M | -$379K | -$50K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | $253K | $0 | $0 | $312K |
| Financing Cash Flow | $1M | $857K | $2M | $1M | $262K |
| Net Change in Cash | -$36K | -$7K | $133K | -$140K | -$8K |
| Cash End of Period | $34K | $28K | $161K | $21K | $12K |
| Free Cash Flow | -$3M | -$864K | -$2M | -$1M | -$271K |